Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “anti-”

1,068 pharma patents match "anti-" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,068
Index total 30,257
Page 33 / 45

Quick answer

This filtered view shows 1,068 pharmaceutical patents matching "anti-" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,068 results for “anti-” · 30,257 patents in full index Clear search

  1. US 9259488

    Anti-C3d antibody conjugates and methods of detecting complement activation

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted

  2. US 9249225

    Single chain variable fragment anti-CD133 antibodies and uses thereof

    Regents of the University of Minnesota · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted

  3. US 9243036

    Anti-microbial activity of synthetic peptides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted

  4. US 9238692

    Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted

  5. US 9233932

    Oligomer-nitroimidazole anti-infective conjugates

    Nektar Therapeutics · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted

  6. US 9220772

    Anti-tumor antigen antibodies and methods of use

    The Regents of the University of California · Granted Dec 29, 2015 · Expires Dec 24, 2035

    granted

  7. US 9216983

    Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity

    The Board of Regents of the University of Texas System · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted

  8. US 9211244

    Method for anti-skin aging using caffeamide derivative

    China Medical University · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

  9. US 9200265

    Anti-cocaine compositions and treatment

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted

  10. US 9193801

    Stabilized formulations containing anti-PCSK9 antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted

  11. US 9187541

    Anti-microbial peptides and methods of use thereof

    The Regents of the University of California · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  12. US 9181327

    Anti-HIV domain antibodies and method of making and using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  13. US 9173880

    Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  14. US 9168269

    Inhibitors of long and very long chain fatty acid metabolism as broad spectrum anti-virals

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  15. US 9168291

    β-mannosylceramide and stimulation of NKT cell anti-tumor immunity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  16. US 9169294

    Anti-angiogenic molecules, nanostructures and uses thereof

    Northwestern University · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  17. US 9161935

    Use of laquinimod for treating Crohn's disease patients who failed first-line anti-TNF therapy

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted

  18. US 9162980

    Anti-depression compounds

    The Board of Regents of the University of Texas System · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted

  19. US 9163085

    Anti-OX40 antibodies and methods of treating cancer

    The Board of Regents of the University of Texas System · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted

  20. US 9150648

    Anti-ASIC1 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted

  21. US 9139634

    Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities

    The Regents of the University of California · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  22. US 9132192

    Anti-EGFR antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  23. US 9127057

    Anti-IL-23 heterodimer specific antibodies

    TEVA PHARMACEUTICALS AUSTRALIA PTY LTD · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted

  24. US 9127053

    Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.